comprehensive -WSS

comprehensive

author：leisure time 2025-10-02 11:09:40 - browse：2

After months of vigorous deliberations, I’m thrilled to announce our 2023 STATUS List — the definitive roster of leaders in health, medicine, and the life sciences whose work over the past year has advanced those fields.

There were, of course, many contenders to choose from. For this second annual list, we’ve selected just 46 — an homage to the number of chromosomes in human DNA. Many are well-known as changemakers; others are largely unheralded heroes. They are CEOs, philanthropists, government officials, and health advocates. All have compelling stories to tell.

Our editorial team painstakingly researched and identified hundreds of finalists. In winnowing down the list, judges placed special emphasis on people who have sought to help others and build community in these often-divisive times. One note: Our news coverage is independent of this list, and we remain committed to tough-minded reporting on the people and institutions shaping life sciences.

While I have your attention, I want to point you to some of our most talked-about exclusive stories in recent days: A new STAT investigation exposes how Medicare Advantage plans use algorithms to cut off care for seniors in need, and we took a closer look at how a Medicare Advantage business is strangling one of its first funders. We’re aggressively reporting on the consequences for biotech of the Silicon Valley Bank collapse.

And over the coming months, in our series “The Obesity Revolution,” we’ll explore a class of obesity drugs that is transforming patients’ lives, dividing medical experts, and spurring one of the biggest business battles in years.

For full access to our exclusive reporting, please consider purchasing a STAT+ subscription. Get 15% off an annual subscription by using promo code STAT15 when you check out.

As always, please reach out to me with feedback. I’m at [email protected].

Previous article： Medical records are filled with copy
Next article： The thinking behind the controversial eating disorder chatbot Tessa

leisure time

knowledge

WSS

A public health expert passes on football's full body collisions for youths

UnitedHealth’s board chair also owns a personal investment firm

FDA struggles to regulate food additives, sometimes for decades

Bispecific antibodies are next new thing in cancer immunotherapy

Pharmacists can make shortage drugs, but at what cost?

CEOs share strategies for surviving biotech slump

entertainment

comprehensive

focus

New air purifier tech could be key to improving indoor air quality

Pioneering cancer drug will cost $475,000. Analysts call it a bargain

Continuity nursing helped my family in our darkest PICU moments

Living organ donors deserve priority status for transplants

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

STAT Summit: Michael J. Fox on progress in Parkinson's research

Trump demands the U.S. pay no more for drugs than other countries … again

STAT Summit: Michael J. Fox on progress in Parkinson's research

BioMarin wins approval for gene therapy to treat hemophilia A

Bispecific antibodies are next new thing in cancer immunotherapy

leisure time

Solve the antibiotic resistance crisis with preventive drugs

How to fix the rural physician shortage in the U.S.

2023 STAT Wunderkinds: get to know the winners

Pioneering cancer drug will cost $475,000. Analysts call it a bargain

Eli Lilly’s Mounjaro succeeds in second weight

A public health expert passes on football's full body collisions for youths

entertainment

leisure time

knowledge

knowledge